These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15372086)

  • 41. CuraGen Corporation.
    Mansfield T; Vincent MR
    Pharmacogenomics; 2002 Jul; 3(4):551-4. PubMed ID: 12164777
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacogenetics.
    Roses AD
    Hum Mol Genet; 2001 Oct; 10(20):2261-7. PubMed ID: 11673409
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genome-wide screening for drug discovery and companion diagnostics.
    Roses AD
    Expert Opin Drug Discov; 2007 Apr; 2(4):489-501. PubMed ID: 23484757
    [TBL] [Abstract][Full Text] [Related]  

  • 44. After the breakthrough. It will take years to turn genetic data into drugs.
    Sherrid P
    US News World Rep; 2001 Feb; 130(8):48. PubMed ID: 11234123
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmacogenetic application in drug development and clinical trials.
    Shi MM; Bleavins MR; de la Iglesia FA
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 2):591-5. PubMed ID: 11259358
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase zero trials: a novel approach in drug development process.
    Fuloria NK; Fuloria S; Vakiloddin S
    Ren Fail; 2013 Aug; 35(7):1044-53. PubMed ID: 23829822
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of new psychotropic drugs following achievements in studies on pharmacogenetics.
    Osaki N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Aug; 31(4):147-8. PubMed ID: 22195322
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmacogenetics and the pharmaceutical industry.
    Raaijmakers JA; Koster ES; Maitland-van der Zee AH
    Curr Pharm Des; 2010; 16(2):238-44. PubMed ID: 20205665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Designing prospective clinical pharmacogenomic (PG) trials: meeting report on drug development strategies to enhance therapeutic decision making.
    Trepicchio WL; Essayan D; Hall ST; Schechter G; Tezak Z; Wang SJ; Weinreich D; Simon R
    Pharmacogenomics J; 2006; 6(2):89-94. PubMed ID: 16402088
    [No Abstract]   [Full Text] [Related]  

  • 50. The future of drugs.
    Elmer-DeWitt P
    Time; 2001 Jan; 157(2):56-7. PubMed ID: 11195689
    [No Abstract]   [Full Text] [Related]  

  • 51. Customized drugs. Designing better treatments.
    Mayo Clin Health Lett; 2002 Aug; 20(8):7. PubMed ID: 12171052
    [No Abstract]   [Full Text] [Related]  

  • 52. Toxicogenetics in drug development.
    Park BK; Pirmohamed M
    Toxicol Lett; 2001 Mar; 120(1-3):281-91. PubMed ID: 11323186
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulatory sciences and translational pharmacogenetics: amitriptyline as a case in point.
    Mifsud Buhagiar L; Micallef B; Borg JJ; Vella H; Serracino Inglott A; LaFerla G
    Drug Metab Pers Ther; 2019 May; 34(2):. PubMed ID: 31145691
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug design in the 21st century (discussion).
    Tanaka T; Kawashima H; Tsujimoto T; Fujino M
    Nihon Yakurigaku Zasshi; 2001 Apr; 117(4):229-42. PubMed ID: 11455934
    [No Abstract]   [Full Text] [Related]  

  • 55. Individualized pharmacogenetic therapy: a critical analysis.
    Schmedders M; van Aken J; Feuerstein G; Kollek R
    Community Genet; 2003; 6(2):114-9. PubMed ID: 14560072
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss-of-function genetic diseases and the concept of pharmaceutical targets.
    Ségalat L
    Orphanet J Rare Dis; 2007; 2():30. PubMed ID: 17674486
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Building a better patient.
    Schulhof J
    Nat Biotechnol; 1997 Apr; 15(4):315-6. PubMed ID: 9094123
    [No Abstract]   [Full Text] [Related]  

  • 58. Decision making in pharmacogenomic diagnosis: is there anything new under the sun?
    Gutman S; Feigal D
    Drug Discov Today; 2003 Sep; 8(17):765-6. PubMed ID: 12946630
    [No Abstract]   [Full Text] [Related]  

  • 59. Postgenomic prospects of success in drug development and pharmacotherapy.
    Rane A
    Pharmacogenomics J; 2001; 1(1):6-9. PubMed ID: 11913729
    [No Abstract]   [Full Text] [Related]  

  • 60. Role of pharmacogenetics in drug development.
    Balant LP; Balant-Gorgia AE
    Psychopharmacol Ser; 1989; 7():211-6. PubMed ID: 2687859
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.